glp-1 agonist Classification of currently available glucagon-like peptide-1 receptor GLP-1 Receptor Agonists as Treatments
Description
Accessed 2025 Apr 25
3 Given it is still in the early days regarding the success and second-order effects of these drugs, its difficult to determine if the impact on various areas of the stock market is short-lived
Conclusion The oral GLP-1 analogue semaglutide is a new drug that adds several benefits to diabetes treatment in addition to blood glucose control
Exploratory analyses highlighted a link between treatment with tirzepatide and amelioration of biomarkers associated with inflammation and atherosclerotic cardiovascular diseases [84]
